
Sign up to save your podcasts
Or
Obesity increases the risk of a range of chronic diseases and negative health outcomes. And trials where a sufficient amount of weight loss is achieved show health improvements. However, despite the “straightforward” nature of causing weight loss through a hypocaloric diet, it is clear that most people who lose weight will regain some or all of the weight.
This is a result of both the physiologic control of intake and expenditure (i.e. homeostatic regulation by the body to avoid staying at a lower body or fat mass), and environmental factors. Diet-induced weight loss is followed by a number of hormonal change that encourage weight regain. So how do we tackle this problem?
In this episode, Dr. Priya Sumithran discusses this physiologic control of body mass, in addition to environmental and behavioural factors that make weight loss maintenance difficult. Dr. Sumithran also discusses what this means for setting weight loss targets, choosing the correct intervention, and looking to non-weight-centric approaches for certain individuals. We also discuss the evidence on GLP-1 receptor agonist drugs, such as Semaglutide, as a treatment for obesity.
Links:
4.8
378378 ratings
Obesity increases the risk of a range of chronic diseases and negative health outcomes. And trials where a sufficient amount of weight loss is achieved show health improvements. However, despite the “straightforward” nature of causing weight loss through a hypocaloric diet, it is clear that most people who lose weight will regain some or all of the weight.
This is a result of both the physiologic control of intake and expenditure (i.e. homeostatic regulation by the body to avoid staying at a lower body or fat mass), and environmental factors. Diet-induced weight loss is followed by a number of hormonal change that encourage weight regain. So how do we tackle this problem?
In this episode, Dr. Priya Sumithran discusses this physiologic control of body mass, in addition to environmental and behavioural factors that make weight loss maintenance difficult. Dr. Sumithran also discusses what this means for setting weight loss targets, choosing the correct intervention, and looking to non-weight-centric approaches for certain individuals. We also discuss the evidence on GLP-1 receptor agonist drugs, such as Semaglutide, as a treatment for obesity.
Links:
2,596 Listeners
4,543 Listeners
5,299 Listeners
1,224 Listeners
377 Listeners
341 Listeners
1,160 Listeners
509 Listeners
2,602 Listeners
7,953 Listeners
720 Listeners
60 Listeners
183 Listeners
377 Listeners
1,140 Listeners